No Data
No Data
Express News | Telesis Bio Inc - on June 6 Received Nasdaq Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersLongeveron (NASDAQ:LGVN) shares rose 112.1% to $1.74 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. vTv Therapeutics (NASDAQ:VTVT) stock i
Vicore Expands and Strengthens Its Board of Directors
STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of
FFIE, OGEN and CCLD Among Mid-day Movers
Telesis Bio in Jeopardy: Risks of Nasdaq Delisting and Financial Instability Loom
Telesis Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Telesis Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.